Pathlight Investors’s Gilead Sciences GILD Stock Holding History

Pathlight Investors’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	$556K	Buy	+8,189	New	+$572K	0.46%	43

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Pathlight Investors's GILD Position: Q4 2018 in Review

Pathlight Investors opened a new position in Gilead Sciences (GILD) in Q4 2018: 8,189 shares worth $556K. The stake represents 0.46% of the portfolio and ranks #43 among its holdings.

1,498 funds tracked by Wall St. Rank hold GILD as of Q4 2018.

Pathlight Investors held 8,189 shares of Gilead Sciences worth $556K as of Q4 2018.
Gilead Sciences was a new Pathlight Investors position in Q4 2018.
Gilead Sciences made up 0.46% of Pathlight Investors's portfolio in Q4 2018, its #43 holding.
1,498 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2018.

Based on Pathlight Investors's 13F filing for Q4 2018, filed 19 Feb 2019.